Spectral Diagnostics (OTCMKTS:EDTXF) Trading Down 1.8% – Time to Sell?

Spectral Diagnostics Inc. (OTCMKTS:EDTXF)’s share price traded down 1.8% during trading on Monday . The company traded as low as $1.00 and last traded at $1.00. 19,291 shares were traded during trading, an increase of 157% from the average session volume of 7,498 shares. The stock had previously closed at $1.0180.

Spectral Diagnostics Stock Up 1.5%

The firm has a market cap of $297.88 million, a P/E ratio of -8.46 and a beta of 0.10. The business has a fifty day moving average of $0.99 and a 200 day moving average of $0.99.

Spectral Diagnostics (OTCMKTS:EDTXF) last posted its quarterly earnings results on Thursday, March 26th. The company reported ($0.01) EPS for the quarter, hitting analysts’ consensus estimates of ($0.01). The business had revenue of $0.28 million for the quarter, compared to the consensus estimate of $0.54 million.

Spectral Diagnostics Company Profile

Spectral Medical Inc focuses on the development and commercialization of products for the treatment of septic shock in the United States, Italy, Ireland, and internationally. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies.